Blood-flow Restricted Exercise in Inclusion Body Myositis

NCT02317094 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2015-10-20

No results posted yet for this study

Summary

This study evaluates the effects of a low-intensity blood-flow restricted exerciser protocol on patient reported physical function, in patients with sporadic inclusion body myositis. The study is designed as a parallel group randomized controlled trial with a treatment group and a control group.

Conditions

  • Sporadic Inclusion Body Myositis

Interventions

OTHER

Blood-flow restricted training

The intervention consists of low-intensity blood-flow restricted training involving 5 lower extremity exercises performed uni lateral in four sets to concentric failure with an intensity of approximately 25 repetition maximum (25RM).

DRUG

Care as usual

The intervention consists of various DMARDs, which are given to the patients depending on their physical state and the disease activity.

Sponsors & Collaborators

  • Odense University Hospital

    collaborator OTHER
  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Anders N Jørgensen, PhD Student · University of Southern Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02317094 on ClinicalTrials.gov